Covered recipient · General Payments record
AMNA MEHDI
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2024
$1,410.33
- Reported across 71 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $311.08 | 17 |
| Education | $76.00 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $182.27 | 11 |
| Janssen Biotech, Inc. | $76.00 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $29.76 | 1 |
| Ferring Pharmaceuticals Inc. | $25.75 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $20.61 | 1 |
| QOL Medical, LLC | $20.55 | 1 |
| Celgene Corporation | $18.48 | 1 |
| Gilead Sciences, Inc. | $13.66 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $13.52 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105014753 | CMS |
| ABBVIE INC. | $18.33 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105014755 | CMS |
| ABBVIE INC. | $14.55 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105014757 | CMS |
| ABBVIE INC. | $10.80 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105014759 | CMS |
| ABBVIE INC. | $23.46 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105014761 | CMS |
| ABBVIE INC. | $24.87 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105014763 | CMS |
| ABBVIE INC. | $12.12 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105014765 | CMS |
| ABBVIE INC. | $7.93 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105014767 | CMS |
| ABBVIE INC. | $22.26 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105014769 | CMS |
| ABBVIE INC. | $15.77 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105014771 | CMS |
| ABBVIE INC. | $18.66 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105014773 | CMS |
| Celgene Corporation | $18.48 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101170468 | CMS |
| Ferring Pharmaceuticals Inc. | $25.75 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137495235 | CMS |
| Gilead Sciences, Inc. | $13.66 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133640612 | CMS |
| Janssen Biotech, Inc. | $76.00 | 04/22/2024 | Education | Undisputed | 01/23/2026 | 1078759418 | CMS |
| QOL Medical, LLC | $20.55 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147730278 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $20.61 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153634576 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $29.76 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137634066 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.